These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 4392071

  • 21. Effect of hypoglycemic agents on liver regeneration.
    Gershbein LL.
    Biochem Pharmacol; 1967 Jun; 16(6):1117-20. PubMed ID: 6040393
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Biosynthesis and release of insulin in organ cultures of fetal rat pancreas].
    Lambert A, Orci L, Kanazawa Y, Renold AE.
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():505-37. PubMed ID: 4313345
    [No Abstract] [Full Text] [Related]

  • 25. ACETOHEXAMIDE: CLINICAL EVALUATION OF A NEW ORAL ANTIDIABETIC AGENT.
    ALTERMAN SL, LIEBER AL.
    Curr Ther Res Clin Exp; 1964 Mar; 6():148-55. PubMed ID: 14131413
    [No Abstract] [Full Text] [Related]

  • 26. The use of diazoxide inhibition of insulin secretion as a tool to investigate insulin stimulation by other agents.
    Gulbenkian A, Ornstein L, Tabachnick II.
    Horm Metab Res; 1972 Mar; 4(2):57-8. PubMed ID: 5028220
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Secretory regulation of endocrine pancreas: Cyclic AMP and glucagon secretion.
    Toyota T, Sato SI, Kudo M, Abe K, Goto Y.
    J Clin Endocrinol Metab; 1975 Jul; 41(1):81-9. PubMed ID: 168230
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The pharmacology and metabolism of oral antidiabetic drugs.
    Bänder A.
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:22-30. PubMed ID: 5005129
    [No Abstract] [Full Text] [Related]

  • 36. [Comparative studies on the effect of sodium glymidine, glucagon and isopropylnoradrenaline on insulin secretion in rats].
    Losert W, Rosenthal K, Jahn P, Sitt R.
    Naunyn Schmiedebergs Arch Pharmakol; 1970 Aug; 266(4):397-8. PubMed ID: 4397505
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [EXPERIMENTAL BASIS FOR COMBINED TREATMENT OF DIABETES WITH THE BIGUANIDE-SULFONAMIDE ASSOCIATION].
    STERNE J, HIRSCH C.
    Diabete; 1964 Aug; 12():171-5. PubMed ID: 14173920
    [No Abstract] [Full Text] [Related]

  • 39. [SIDE-EFFECTS IN THE ORAL TREATMENT OF DIABETES WITH SULFONYLUREAS].
    OSTMAN J, GROENBERG A.
    Nord Med; 1964 Nov 19; 72():1388-95. PubMed ID: 14210083
    [No Abstract] [Full Text] [Related]

  • 40. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
    SMITH DL, VECCHIO TJ, FORIST AA.
    Metabolism; 1965 Mar 19; 14():229-40. PubMed ID: 14261407
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.